Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 9th DDR Inhibitors Summit.

Jennifer Castro, Director of Translational & Discovery Biology at Accent Therapeutics, speaker for 9th DDR Inhibitors Summit

Jenn Castro

Director of Translational and Discovery Biology
Accent Therapeutics
Michail Shipitsin, Vice President Biomarker Development at Acrivon Therapeutics, speaking at DDR Inhibitors Conference

Michail Shipitsin

Vice President Biomarker Development
Acrivon Therapeutics
Ian Smith, Chief Medical Officer at Artios Pharma, speaker at DDR Inhibitors Summit 2026

Ian Smith

Chief Medical Officer
Artios Pharma
Graeme Smith, Chief Scientific Officer at Artios Pharma, speaker at DDR Inhibitors Summit

Graeme Smith

Chief Scientific Officer
Artios Pharma
Jon Hollick, Managing Director & Head of Research, Breakpoint Therapeutics, speaking at DDR Inhibitors Summit 2026

Jon Hollick

Managing Director & Head of Research
Breakpoint Therapeutics
Michael Torres, Chief Executive Officer, CrossBridge Bio, speaker for DDR Inhibitors Summit

Michael Torres

CEO
CrossBridge Bio
Alan D’Andrea, Director of the Center for DNA Damage and Repair at Dana-Farber Cancer Institute, speaker at DDR Inhibitors Summit

Alan D’Andrea

Director of the Center for DNA Damage and Repair
Dana-Farber Cancer Institute
Luke Piggott Principal Scientist & Director Business Development at Debiopharm, speaker at 9th DDR Inhibitors Summit

Luke Piggott

Director, Business Development
Debiopharm
Andreas Ladurner

Andreas Ladurner

Founder, Managing Director & Chief Scientific Officer
Eisbach Bio
Jatinder (Jyoti) Mukker, Senior Director & Portfolio Section Head, Quantitative Pharmacology at EMD Serono, an affiliate of Merck KGaA, speaking at DDR Inhibitors Summit

Jatinder Mukker

Head Senior Director, Quantitative Pharmacology Portfolio Section
EMD Serono, an affiliate of Merck KGaA

Ioannis Gounaris

Vice President - Clinical Development
EMD Serono, an affiliate of Merck KGaA
Martin Taylor

Martin Taylor

Principal
F-Prime Capital
Irena Konstantinova, Head of Biology at FoRx Therapeutics, speaker at 9th DDR Inhibitors Summit 2026

Irena Konstantinova

Head of Biology
FoRx Therapeutics AG
Samuel Rabkin, Professor of Neurosurgery at Massachusetts General, speaker at DDR Inhibitors Summit 2026 Hospital

Samuel Rabkin

Professor of Neurosurgery
Massachusetts General Hospital and Harvard Medical School
Jann Sarkaria, Professor of Radiation Oncology Medical & Health at Mayo Clinic, speaker for DDR Inhibitors Summit

Jann Sarkaria

consultant
Mayo Clinic
Ranjit Bindra, Co-Founder & Professor, Co-Director, Brain Tumor Center at Modifi Bio (Acquired by Merck & Co) & Yale University, speaker at DDR Inhibitors Summit

Ranjit Bindra

Co-Founder & Professor, Co-Director, Brain Tumor Center
Modifi Bio
Julian Blagg, VP Drug Discovery & Chair of Scientific Advisory Board at NeoPhore, speaking at 9th DDR Inhibitors Summit

Julian Blagg

VP Drug Discovery & Chair of Scientific Advisory Board
NeoPhore
Katherine Pawelczak, Chief Operating Officer at Nerx BioSciences, speaking at DDR Inhibitors Summit

Katherine Pawelczak

Chief Operating Officer & Vice President - Research
Nerx BioSciences Inc.
Eli Rothenberg

Eli Rothenberg

Professor of Biochemistry, Molecular Pharmacology, Biomedical Engineering & Director, Single-Molecule Biophotonics
NYU Langone Health
Shridar Ganesan, MD Director, Center for Molecular Oncology Perlmutter Cancer at NYU Langone Health, speaker at DDR Inhibitors Meeting

Shridar Ganesan

Professor
Perlmutter Cancer NYU Langone Health
Jack Cheng, Associate Director - Preclinical Research at PharmaEngine, Inc, speaker at 9th DDR Inhibitors Meeting

Jack Cheng

Associate Director
PharmaEngine, Inc
Mads Daugaard, Co-founder, President, Chief Scientific Officer & Associate Professor, Department of Urologic Science at Rakovina Therapeutics & University of British Columbia, speaker at DDR Inhibitors Conference

Mads Daugaard

Co-founder, President & Chief Scientific Officer
Rakovina Therapeutics, Inc.
Sotirios Sotiriou, Principal Scientist -pRED Oncology at Roche, speaker for DDR Inhibitors Conference

Sotirios Sotiriou

Principal Scientist
Roche
Philip Beer, Chief Scientific Officer, CSO at Step Pharma, speaking at DDR Inhibitors Summit

Philip Beer

Chief Scientific Officer
Step Pharma
Yuka Kumagai, Senior Vice President & Head of Translational Research & Medicine at Sumitomo Pharma - Speaking at 9th DDR Inhibitors Summit

Yuka Kumagai

Associate Director, Translational Research, Oncology
Sumitomo Pharma America, Inc.
Vice President & Head of Clinical Development & Therapeutics Discovery Medical, Institute For Applied Cancer Science at MD Anderson Cancer Center, speaker for DDR Inhibitors Summit

Timothy Yap

Professor
The University of Texas MD Anderson Cancer Center
Zakia Belaid-Sandal, Chief Executive Officer & Co-Founder at Theranovir, speaking at DDR Inhibitors Summit 2026

Zakia Belaid-Sandal

CEO/CSO
Theranovir
Anthony Chalmers, Professor & Clinical Oncology Chair at University of Glasgow, speaker at DDR Inhibitors Conference

Anthony Chalmers

Professor & Clinical Oncology Chair
University of Glasgow
Ivan Ahel, Professor of Chemical Pathology at University of Oxford, Speaker at DDR Inhibitors Summit

Ivan Ahel

EP Abraham Professor of Chemical Pathology
University of Oxford
David Mankoff, Professor Radiology at University of Pennsylvania, speaker for DDR Inhibitors Conference

David Mankoff

Professor of Radiology
University of Pennsylvania
Roger Greenberg, Professor of Cancer Biology at University of Pennsylvania, speaking at 9th DDR Inhibitors Summit

Roger Greenberg

Professor of Cancer Biology
University of Pennsylvania
Eric Brown, Associate Professor & Scientific Consultant at University of Pennsylvania, speaker at DDR Inhibitors Summit

Eric J. Brown

Associate Professor
University of Pennsylvania
Hyun-Ho Lee, Chief Technology Officer & Head of R&D at VSPharmTech, speaker at DDR Inhibitors

Hyunho LEE

CTO
VSPharmTech
Wei Zhong, Chief Executive Officer at Wayshine Pharma, speaking at DDR Inhibitors Summit

Wei Zhong

Chief Executive Officer
Wayshine Biopharm
Viewing poster
Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

View Presentations & Speakers
Explaining poster
Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options
poster session socialising
Join DDR Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.

Register Now